Hepatitis C antigen—antibody combination assay for the early detection of infection
US6723502B2 · kind B2 · utility
4Cited by
3References
2Claims
0Family size
Inventors
Key dates
| Filing date | Mar 28, 2002 |
| Grant date | Apr 20, 2004 |
| Priority date | — |
| Expiry date | Mar 28, 2022 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N33/5767
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Described herein is an ELISA based assay for the detection of HCV infection. This new assay can detect HCV infection earlier than the currently used assays for the screening of blood for HCV infection by using a combination of HCV antigens and anti-core antibodies to capture HCV.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.